Dendritic Cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo
Open Access
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in BMC Immunology
- Vol. 9 (1), 15
- https://doi.org/10.1186/1471-2172-9-15
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challengeProceedings of the National Academy of Sciences of the United States of America, 2004
- Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypoxNature, 2004
- Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine virusesProceedings of the National Academy of Sciences of the United States of America, 2003
- Biology of Attenuated Modified Vaccinia Virus Ankara Recombinant Vector in Mice: Virus Fate and Activation of B- and T-Cell Immune Responses in Comparison with the Western Reserve Strain and Advantages as a VaccineJournal of Virology, 2000
- Edward Jenner and the Eradication of SmallpoxScottish Medical Journal, 1997
- Nonreplicating vaccinia vector efficiently expresses recombinant genes.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulenceJournal of General Virology, 1991
- [The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)].1978
- Complications of smallpox vaccination United States 1963. II. Results obtained by four statewide surveys.1967
- Complications of Smallpox VaccinationNew England Journal of Medicine, 1967